EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Opioid Use in Cancer Pain Management: Navigating the Line Between Relief and Addiction

Maite Trullols, Vicenç Ruiz de Porras iD

International Journal of Molecular Sciences · 01.08.2025 · 26 (15) · 7459

DOI: 10.3390/ijms26157459 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.08.2025. Verfasst von Maite Trullols und 1 weiteren Autor:innen. Beteiligte Einrichtung: GRET and Toxicology Unit, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barc…. Hauptthemen laut MEDLINE: Cancer Pain, Analgesics, Opioid, Opioid-Related Disorders, Pain Management. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of opioids for cancer-related pain is essential but poses significant challenges due to the risk of misuse and the development of opioid use disorder (OUD). This review takes a multidisciplinary perspective based on the current scientific literature to analyze the pharmacological mechanisms, classification, and therapeutic roles of opioids in oncology. Key risk factors for opioid misuse—including psychiatric comorbidities, prior substance use, and insufficient clinical monitoring—are discussed in conjunction with validated tools for pain assessment and international guidelines. The review emphasizes the importance of integrating toxicological, pharmacological, physiological, and public health perspectives to promote rational opioid use. Pharmacogenetic variability is explored as a determinant of treatment response and addiction risk, underscoring the value of personalized medicine. Evidence-based strategies such as early screening, psychosocial interventions, and the use of buprenorphine-naloxone are presented as effective measures for managing OUD in cancer patients. Ultimately, this work advocates for safe, patient-centered opioid prescribing practices that ensure effective pain relief without compromising safety or quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer PainAnalgesics, OpioidOpioid-Related DisordersPain ManagementNeoplasmsHumansQuality of Life

Stichwörter der Autor:innen

addiction preventioncancer-related painopioid use disorderopioidspain managementpersonalized medicinepharmacogenetics

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • GRET and Toxicology Unit, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.

ORCID-Profile: Vicenç Ruiz de Porras

Zitieren

APA

Trullols, M., & Ruiz de Porras, V. (2025). Opioid Use in Cancer Pain Management: Navigating the Line Between Relief and Addiction. International Journal of Molecular Sciences, 26(15), 7459. https://doi.org/10.3390/ijms26157459

Vancouver

Trullols M, Ruiz de Porras V. Opioid Use in Cancer Pain Management: Navigating the Line Between Relief and Addiction. International Journal of Molecular Sciences. 2025;26(15):7459. doi:10.3390/ijms26157459

BibTeX
@article{Trullols2025,
  author = {Trullols, Maite and Ruiz de Porras, Vicenç},
  title = {Opioid Use in Cancer Pain Management: Navigating the Line Between Relief and Addiction},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {15},
  pages = {7459},
  doi = {10.3390/ijms26157459}
}
Kostenlos starten →